REGENXBIO (RGNX) Short Interest Ratio & Short Volume → Could this Tiny Biotech End Disease Forever? (From Behind the Markets) (Ad) Free RGNX Stock Alerts $16.67 -0.29 (-1.71%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability REGENXBIO Short Interest DataCurrent Short Volume4,070,000 sharesPrevious Short Volume3,950,000 sharesChange Vs. Previous Month+3.04%Dollar Volume Sold Short$73.34 millionShort Interest Ratio / Days to Cover5.6Last Record DateApril 15, 2024Outstanding Shares49,040,000 sharesPercentage of Shares Shorted8.30%Today's Trading Volume326,222 sharesAverage Trading Volume681,060 sharesToday's Volume Vs. Average48% Short Selling REGENXBIO ? Sign up to receive the latest short interest report for REGENXBIO and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRGNX Short Interest Over TimeRGNX Days to Cover Over TimeRGNX Percentage of Float Shorted Over Time Ad Behind the MarketsCould this Tiny Biotech End Disease Forever?Imagine a revolutionary treatment capable of editing out ANY disease. By literally "cutting" the genetic instructions that cause illness, and "pasting" in corrected DNA to restore perfect health.Access my full "Cut & Paste" profit analysis now. REGENXBIO Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20244,070,000 shares $73.34 million +3.0%N/A5.6 $18.02 3/31/20243,950,000 shares $83.23 million -4.8%N/A5.2 $21.07 3/15/20244,150,000 shares $92.09 million +8.4%N/A5.2 $22.19 2/29/20243,830,000 shares $66.80 million -8.2%9.6%5.1 $17.44 2/15/20244,170,000 shares $76.94 million +0.5%10.6%6.9 $18.45 1/31/20244,150,000 shares $51.13 million -5.9%10.6%7.1 $12.32 Get the Latest News and Ratings for RGNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for REGENXBIO and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,410,000 shares $66.72 million +6.3%11.2%8 $15.13 12/31/20234,150,000 shares $74.49 million +4.0%10.6%7.9 $17.95 12/15/20233,990,000 shares $79.64 million +2.8%10.0%8.1 $19.96 11/30/20233,880,000 shares $75.74 million -4.4%9.7%8.6 $19.52 11/15/20234,060,000 shares $77.71 million -1.9%10.2%9.2 $19.14 10/31/20234,140,000 shares $53.36 million -2.6%10.4%10.7 $12.89 10/15/20234,250,000 shares $68.38 million +6.3%10.7%11.8 $16.09 9/30/20234,000,000 shares $65.84 million -8.7%10.1%11.5 $16.46 9/15/20234,380,000 shares $77.88 million +1.9%11.0%13.2 $17.78 8/31/20234,300,000 shares $76.11 million -1.4%10.8%12.3 $17.70 8/15/20234,360,000 shares $78.61 million -2.7%11.0%11.8 $18.03 7/31/20234,480,000 shares $85.12 million -1.1%11.3%11.3 $19.00 7/15/20234,530,000 shares $85.44 million +1.1%11.5%11.4 $18.86 6/30/20234,480,000 shares $89.56 million -1.3%11.4%10.8 $19.99 6/15/20234,540,000 shares $89.21 million -5.2%11.5%10.5 $19.65 5/31/20234,790,000 shares $82.53 million -1.4%12.2%11.1 $17.23 5/15/20234,860,000 shares $105.51 million +2.5%12.3%10.9 $21.71 4/30/20234,740,000 shares $91.77 million +1.5%12.0%10.9 $19.36 4/15/20234,670,000 shares $88.54 million +3.3%11.8%10.8 $18.96 3/31/20234,520,000 shares $85.47 million +1.8%11.6%10.5 $18.91 3/15/20234,440,000 shares $92.40 million +6.5%11.4%11 $20.81 2/28/20234,170,000 shares $92.78 million +11.8%10.7%10.5 $22.25 2/15/20233,730,000 shares $83.74 million +13.7%9.6%10.4 $22.45 1/31/20233,280,000 shares $76.13 million +7.2%8.5%9.2 $23.21 1/15/20233,060,000 shares $75.12 million +9.7%7.9%8.8 $24.55 12/30/20222,790,000 shares $63.28 million +9.4%7.2%8.1 $22.68 12/15/20222,550,000 shares $58.73 million +10.9%6.5%7 $23.03 11/30/20222,300,000 shares $54.97 million -8.4%5.9%6.8 $23.90 11/15/20222,510,000 shares $55.14 million -6.0%6.4%7.2 $21.97 10/31/20222,670,000 shares $63.20 million +3.9%6.8%7.8 $23.67 10/15/20222,570,000 shares $57.49 million -12.0%6.6%7.4 $22.37 9/30/20222,920,000 shares $77.18 million -0.7%7.5%8 $26.43 9/15/20222,940,000 shares $79.17 million -6.1%7.5%8.2 $26.93 8/31/20223,130,000 shares $92.34 million -6.3%8.0%8.2 $29.50The Weight Loss Pill That Could Disrupt a $32 Billion Industry (Ad)A revolutionary new weight loss pill is about to send shockwaves through the plus-size clothing market. Analysts are calling it the "King Kong" of diet drugs after amazing clinical trial results.Don't miss out on the "next Ozempic" >>> RGNX Short Interest - Frequently Asked Questions What is REGENXBIO's current short interest? Short interest is the volume of REGENXBIO shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 4,070,000 shares of RGNX short. Learn More on REGENXBIO's current short interest. What is a good short interest ratio for REGENXBIO? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGNX shares currently have a short interest ratio of 6.0. Learn More on REGENXBIO's short interest ratio. Is REGENXBIO's short interest increasing or decreasing? REGENXBIO saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 4,070,000 shares, an increase of 3.0% from the previous total of 3,950,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does REGENXBIO's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to REGENXBIO: CARGO Therapeutics, Inc. (13.21%), Mesoblast Limited (0.63%), Immatics (10.60%), HilleVax, Inc. (2.83%), BioCryst Pharmaceuticals, Inc. (16.67%), Relay Therapeutics, Inc. (8.05%), Novavax, Inc. (31.17%), Exscientia plc (3.70%), Autolus Therapeutics plc (1.53%), Valneva SE (0.07%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short REGENXBIO stock? Short selling RGNX is an investing strategy that aims to generate trading profit from REGENXBIO as its price is falling. RGNX shares are trading down $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against REGENXBIO? A short squeeze for REGENXBIO occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RGNX, which in turn drives the price of the stock up even further. How often is REGENXBIO's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGNX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: CRGX Short Interest Data MESO Short Interest Data IMTX Short Interest Data HLVX Short Interest Data BCRX Short Interest Data RLAY Short Interest Data NVAX Short Interest Data EXAI Short Interest Data AUTL Short Interest Data VALN Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RGNX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressHe Is Giving Away BitcoinCrypto Swap ProfitsThe AI Stock that’s Disrupting Every IndustryStockEarnings